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Abstract: Sulfur mustard (SM), is an alkylating agent and has been emerged as a chemical weapon in various battlefields. More recently, 
SM was employed in the Iraq conflict against Iranian military forces and civilians. Nowadays there are more than 40,000 people 
suffering from pulmonary lesions special chronic obstructive pulmonary disease (COPD) due to mustard gas in Iran. SM causes the 
endogenous production of reactive oxygen species (ROS).
Heme oxygenases (HOs) are the rate-limiting enzyme for heme metabolism. Numerous studies have confirmed that HOs are concerned 
in diverse biological processes such as anti-oxidation.
The present study was undertaken to consider the regulation of HO-1 and HO-2 n the human airway wall, and to suggest a probable role 
that HOs may play in cellular defense against oxidative stress due to SM.
In this research ten unexposed SM individuals and twenty SM exposed patients were included. Evaluation of HO-1& HO -2 expressions in 
unexposed and SM exposed patients samples was performed by semiquantitative RT-PCR, real-time RT-PCR and Immunohistochemistry 
analysis.
While unexposed SM samples expressed same levels of HOs, expression level of HO-1was upregulated about 3.58 ± 1.93 folds in SM 
exposed patients in comparison with unexposed ones, we could not find any difference in expression of HO-2 n two groups. In contrast, 
Immunohistochemistry results showed negative HO-1 protein expression in SM injured patients.
Our results revealed that HO1 may plays an important role in cellular protection against oxidative stress due to mustard gas toxicity 
in airway wall of SM exposed patients at mRNA level, but translational modifications might cause decrease in the amount of HO1 
protein.
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Sulfur Mustard (SM) or bis-2-(chloroethyl) sulfide, 
has been emerged as an important chemical weapon 
and is classified as a destructive warfare agent.1 It has 
been used in several battlefields around the globe and 
was employed during World War I for the first time.1–3 
Since then, within the Iran-Iraq war of the 1980s, 
there was extensive usage of SM by Iraqi ex-regime 
against Iranian civilians and military forces.4
This  agent  causes  acute  and  late  complications 
which have their own characteristic features. 20 years 
after encountering SM, side effects of initial expo-
sure to SM, is able to produce severe damage among 
exposed individuals, mainly in skin, eyes, lungs and 
respiratory tracks.5,6
To date there are more than 40,000 people with 
different  degrees  of  involvement  undergoing  late 
respiratory  complications  due  to  SM  exposure.7 
There is no general agreement about the pulmonary 
pathophysiology of the patient population who were 
exposed  to  SM,  but  chronic  bronchitis,  chronic 
obstructive pulmonary disease (COPD), asthma and 
bronchiolitis obliterans (BO) are the most abundant 
long-term  respiratory  diseases  as  the  underlying 
causes.4,6,8
Despite  much  research,  the  precise  mechanism 
by which SM causes late respiratory diseases is still 
poorly understood. SM as an alkylating agent able to 
interact with nucleophilic functional groups such as 
amino, carboxylic and hydroxyl in DNA which refers 
to the mutagenic effect of SM and stable alteration 
in genome.3,6,9 Beside the alkylation of DNA, another 
theory for the late effect of SM is neutrophil and/or 
lymphocyte dominant disorder secret proteases and 
themselves  manufacture  reactive  oxygen  species 
(ROS).10
These hazardous species are recognized to cause 
oxidative injury in a number of molecules in cells. 
The  probable  harmful  effects  of  these  species  are 
controlled by a cellular antioxidant protection which 
comprise enzymes9 such as hemeoxygenases (HOs).
HO is a microsomal enzyme accelerating the first 
rate-limiting stage in the breakdown of heme. It cleaves 
the α-meso carbon of b-type heme to produce equiva-
lent amounts of biliverdin IXa (BV), carbon monox-
ide (CO), and ferrous iron.11–14 Two main mammalian 
HO isoforms have been recognized: HO-1 is a 32-kDa 
protein and an inducible isoform15 via various stimuli, 
remarkably expressed in the liver and spleen. HO-2 is 
a 36-kDa and non-inducible isoform, and exists in the 
brain, endothelial cells or testes.11,16,17
Activation of HO, especially HO-1 can also be 
stimulated by multiple nonheme products16 such as 
glutathione  depletors,12  UV  irradiation,  endotoxin, 
heavy  metals,  heat  shock,  nitric  oxide  (NO), 
inflammatory cytokines and ROS.11,13,14 The possible 
explanation for activity of HO in these cases is that 
it may function as a vital cytoprotective molecule.14 
HO-1 is induced in the lung during stressful situations 
to  counter  with  oxidative  injury  and  maintain 
homeostasis in lungs.18
Although  HO  causes  reduction  of  oxidative 
stress and attenuation of inflammatory reactions due 
to  heme  removal,  which  is  a  powerful  prooxidant 
factor11  anti-oxidant  activity  of  HO  returns  to  its 
byproducts. Indeed the liberated CO induces soluble 
guanylyl cyclase (sGC), in this way reduces leukocyte 
adhesion,  stops  platelet  aggregation19  and  inhibits 
muscle  cell  proliferation.20  Biliverdin  is  promptly 
converted  to  bilirubin  via  Biliverdin  reductase21 
which is an effective antioxidant, because bilirubin 
can  scavenge  ROS  and  decrease  its  production.14 
Ferrous iron released by HO, induces the synthesis 
of ferritin, the iron storage protein, and cytosolic iron 
efflux,  consequently  protects  cells  from  oxidative 
stress.14,18
By  considering  the  production  of  ROS  in  lung 
injury induced by SM, this research will highlight 
the roles of HO-1 and HO-2 in pathophysiological 
cytoprotection  of  the  airway  wall  at  mRNA  and 
protein levels in bronchial biopsies of patients who 
were exposed to SM in comparrison to unexposed 
ones. In addition, this finding will be useful to dem-
onstrate a new method of treatment of SM exposed 
patients with antioxidant medicine.
Methods
Sampling
In this study 20 SM exposed patients and 10 healthy 
participants  were  comprised. The  exposed  patients 
were individuals who had a documented encounter 
with SM within the Iran–Iraq war. Tissue was donated 
by volunteers under conditions of informed consent 
and this survey was conducted in accordance with a 
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University (BMSU) ethics committee.
Data  such  as  age,  gender  were  obtained,  as  is 
shown  in  Table  1.  The  average  age  of  exposed 
individuals  was  about  43.2  ±  6.4,  and  the  mean 
age of non-exposed volunteers was approximately 
41.3 ± 2.5. Cases with positive history of cigarette 
smoking, elderly patients, addicts, pre-exposure of 
pulmonary disease such as asthma, lung cancer or 
respiratory infections and history of countering to 
toxic agents were excluded from our study.
In respect to obtaining biopsies from the bronchi wall, 
the flexible fiberoptic bronchoscopy (FFB) (Olympus 
BF1T, Tokyo, Japan) was performed. Patients were 
topically  anaesthetized  by  applying  2%  Lidocaine. 
Throughout the bronchoscopy, supplementary oxygen 
was given. To obtain endobronchial biopsy samples, 
bronchoscope forceps (Olympus, Tokyo, Japan) were 
passed through the route of fiberoptic bronchoscopy 
to  reach  the  segmental  and  subsegmental  carinae. 
Biopsy  specimens  obtained  were  put  in  Tripure 
Isolation Reagent (Roche Applied Science, Germany) 
and formaline as well. Samples in Tripure Isolation 
Reagent were stored at −80 °C until RNA extraction 
and samples in formaline were placed in the fridge in 
order to undertake immunohistochemistry studies.
RNA extraction
Total  RNA  was  extracted  in  conformity  with  the 
manufacturer’s  recommendations  using  Tripure 
Isolation Reagent (Roche Applied Science, Germany). 
For the first step, bronchi biopsies were homogenated 
in Tripure Isolation Reagent by the mean of Ultra 
Sonic  Homogenator  (Hielscher,  Germany).  The 
aqueous phase containing RNA was separated and to 
avoid contamination with proteins, the lowest fraction 
of aqueous phase was not incorporated in the total 
RNA sample. Following the previous stage, isolated 
RNA was eluted in RNase-free water and the quantity 
and integrity of RNA were measured by NanoDrop 
spectroscopy (ND-1000, Wilmington, DE).
Semiquantitative RT-PCR
500 ng of total RNA was reverse-transcribed to create 
single-strand complementary DNA by SuperScript III 
reverse  transcriptase  (Invitrogen,  Carlsbad,  CA) 
according to the manufacturer’s protocol followed by 
DNaseI (Invitrogen, Carlsbad, CA) treatment and heat 
inactivation,  to  remove  any  residual    chromosomal 
DNA. 1 µl of the resulting cDNA were validated with 
PCR in a volume of 25 µl, containing 2.5 µl 10X 
buffer  (Takara,  Japan),  5  PM    deoxynucleoside   
triphosphate (Takara, Japan), 0.3 µl rTaq polymerase 
Enzyme (Takara, Japan) and 10 PM Primer Mix. The 
interested designed primers are listed below: HO-1 
forward,  5′-ATGACACCAAGGACCAGAGC-3′, 
reverse, 5′-GTGTAAGGACCCATCGGAGA-3′, HO-2 
forward, 5′GGAAACCTCAGAGGGGGTAG-3′, reverse, 
5′-GTGGCCAGCTTAAACAGCTC-3′  and  β-actin 
as a housekeeping gene, forward, 5′- TTCTA CAAT-
GAGCTGCGTGTGG-3′; reverse, 5′-GTGTT GAAG 
GTCTCAAACATGAT-3′  was  purchased  from 
Bioneer (South Korea). PCR was carried out in the 
same situation, heat held at 94 °C for 5 min, denatur-
ation at 94 °C for 30 sec, annealing at 57 °C for 30 sec, 
extension at 72 °C for 1 min (30 cycle) and terminal 
extension at 72 °C for 5 min. PCR products were 
separated on a 2% agarose gel electrophoresis and the 
quantity of bands was visually detectable under UV 
light after staining with ethidiumbromide.
Quantitative real-time PCR
For  real-time  quantitative  PCR,  500  ng  of  RT 
product was used in whole volume of 15 µl consisting 
7.5 µl of SYBR Green Premix 2X (Takara, Shiga, 
Japan)  and  10  PM  of  mix  primer  by  Rotor-Gene 
RG  3000  (Corbett  Research,  Sydney,  Australia). 
Thermocycling conditions were; heat hold at 94 °C 
for  1  min  followed  by  40  cycles  of  denaturation 
at 94 °C for 20 sec, annealing at 57 °C for 30 sec, 
extention at 72° C for 30 sec. The   quantity of each 
gene expression depends on the cycle at threshold 
(Ct) in which the fluorescence density in PCR micro-
Table 1. Subject.
Group n sex (M/F) Age range Age mean ± sD P
Control group 10 10/0 39.0−44.0 41.3 ± 2.5 0.64
SM-injured group 20 20/0 36.0−58.0 43.2 ± 6.4
HO1 expression in bronchial biopsies after long term exposure to sulfur mustard
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β-actin as our endogenous reference gene.
Immunohistochemistry
For  immunohistochemistry  12  SM  exposed  patients 
and  8  control  samples  were  enrolled.  We  have 
already  described  the  details  of  immunohis- 
tochemistry technique elsewhere.22 In summary, air-
way wall biopsy tissues were placed in 4% buffered 
paraformaldehyde for fixation for one day. The Sec-
tions  were  incubated  overnight  with  a  phosphate 
buffer comprised 30% sucrose. Tissues, 20 µm in 
thickness,  were  cut  on  a  cryostat  and  incubated 
with HO-1 antibody at proper density for 12 h at 
4 °C. The antibody employed in this study was a rat 
monoclonal antibody raised against HO of human 
source  (Santa  Cruz  Biothechnology,  Inc,  USA) 
at a dilution 1:200. After incubation with the pri-
mary antibody, the Sections were washed with PBS 
and incubated with biotinylated anti-rat secondary 
antibody (Santa Cruz Biothechnology, Inc, USA). 
For  immunostaining  the  tissues  were  afterward 
detectable using ABC complex (avidin-biotinylated 
peroxidase  complex)  system  (Vector  Laboratory, 
Burlingame, CA, USA) with DAB as a substrate.
Statistical analysis
Data were revealed as mean ± SD of fold-changes 
of  HOs  gene  expression  in  three  independent 
experiments. SPSS software version 15.0 (SPSS, IL) 
was employed for statistical analyses. For evaluation 
of differences in mentioned genes expression between 
SM-injured  group  and  unexposed  group  student’s 
t-test  was  used  and  P  ,  0.05  was  considered  as 
significant.
Results
Clinical features
In this study a total of 20 subjects who had experi-
enced exposure to SM and 10 unexposed participants 
were recruited as controls (Table 1).
Expression of the HO isoforms  
in bronchial wall
It has been shown that two main HO isoforms, HO-1 
and HO-2 are involved in degradation of heme. Only 
HO-1 is an inducible form and is activated via external 
stimuli11,16,17 Fig. 1 shows the mRNA expression levels 
of HO-1 and HO-2 in SM exposed and unexposed ones 
obtained from Semiquantitative RT-PCR. Significant 
HO-1 expression of SM exposed patients compared to 
unexposed ones was observed. HO-2 was also demon-
strable in all specimens, but levels of HO-2 expression 
did not show any notable differences between patients 
exposed to SM and unexposed group.
To  determine  the  fold  changes  in  expression 
quantity  of  target  genes,  HO-1  and  HO-2  mRNA 
levels  were  measured  by  Real-time  RT-PCR.  Test 
samples of all exposed to SM elicited 3.58 ± 1.93 
fold increase in HO-1 mRNA expression in compare 
to unexposed group (P = 0.01). But we could not find 
increased expression of HO-2 mRNA in comparison 
to unexposed group (P = 0.413) (Table 2).
Localization of HO-1  
by immunohistochemistry
To  consider  whether  SM  causes  the  expression  of 
HO-1  in  protein  level,  immunohistochemistry  was 
carried out. A basal expression of HO-1 was visible in 
the bronchial epithelial cells of all members of the unex-
posed group. The thickness of bronchial epithelium 
increased in all SM- exposed patients and this may 
be one of the important reasons for the obstructive 
condition. HO-1 immunopositivity strongly expressed 
in epithelial cells of the unexposed group especially 
in  luminal  border  of  epithelium  and  nucleuses  as 
well (Fig. 2A). In contrast in SM- exposed patients 
immunoreactiovity for HO-1 in the same cells were 
negative (Fig. 2B).
Discussion
In this study we demonstrated that bronchial biopsy 
of  patients  with  history  of  exposure  to  SM  was 
active in upregulating expression of HO-1 at mRNA 
levels in comparison to unexposed ones, wheras we 
could  not  identify  any  considerable  differences  in 
HO-2 transcripts between SM  exposed groups and 
unexposed groups. The main reason for this result is 
that despite of HO-1, HO-2 is not an inducible isoform 
and constitutively expressed for the most part of the 
body.11,16,17
Our findings are approximately consistent with 
previous  studies  in  that  up-regulation  of  HO-1 
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Figure 1. Expression levels of HO-1 and HO-2 in bronchial wall of patients with long term exposure to sulfur mustard. Total RNAs were purified and then 
analyzed by Semiquantitative RT-PCR. This panel shows gel bands in order to PCR amplification products of HO-1 (153 bp), HO-2 (198 bp) and β-actin 
(119 bp) transcripts. A) A marked increase in HO-1 expression levels of SM exposed patients (Lanes 3–13) was recognized in compare to expression level 
of unexposed ones (Lanes 1 and 2). B) The density band of HO-2 in SM exposed patients did not show any highlight deference with mRNA of unexposed 
group. c) Beta-actin was used as internal control. Lane M shows DNA ladder (100 bp).
Table  2.  Increases  in  HOs  expression  in  SM-exposed 
patients in comparison with control group. 
Gene/ 
case group 
sM-exposed cases  
vs. unexposed 
cases (fold changes)
P
Heme oxygenase-1  
(HO-1)
  3.58 ± 1.93 0.019*
Heme oxygenase-2  
(HO-2)
0.115 ± 0.13 0.413
note: *Statistical significance: P , 0.05.
mRNA expression has been revealed under oxidative 
stress  situation.  As  Maeshima  showed,  HO-1 
activity could also be stimulated by a diversity of 
nonheme products such as heavy metals, endotoxin, 
UV and hydrogen peroxide, which is one of the most 
important oxidant.23 The common aspect of these 
inducers is their ability to produce ROS.23 It has 
been also proved that SM consequently causes GSH 
depelation and generates ROS as cited previously. 
In this situation HO-1 can be overexpressed as a 
compensatory  antioxidant  when  GSH  is  depleted 
and acts as a cytoprotective component against oxi-
dative stress.24,25 Indeed, extensive studies presently 
support  the  belief  that  HO-1  serves  to  provide 
effective cytoprotective role in various in vitro and 
in vivo models of cellular and tissue damage induced 
by oxidants.26–28
HO-1 is complicated in cytoprotection of several 
airway and lung diseases such as chronic obstructive 
pulmonary  disease  (COPD),  asthma  and  acute 
respiratory distress syndrome (ARDS).20 Accumulat-
ing evidences reveals the importance of HO-1 in the 
pathogenesis of COPD. For example, smoking has 
been proved to increase the expression of HO-1 in 
airway tissues.29
Subsequent studies have clarified that HO-1 mRNA 
levels increased in airways of subjects with asthma 
than in normal cases. HO-1 might have an inhibitory 
implication in progression of lung remodeling which 
is observed in asthma.20,30
Other research shows that increased HO-1 activity 
in lung epithelial cells protects cells against hyperoxic 
injury. In vivo, exogeneous management of HO-1 to 
rats by means of a recombinant adenovirus express-
ing HO-1 considerably decreased acute lung injury 
induced by hyperoxia.20 Similarly, increased expres-
sion levels of HO-1 in the bronchiolar epithelium via 
adenoviral transferred gene, the rats were protected 
against damage when consequently encountered to 
hyperoxia.18,27
It has been also reported that HO-1 plays an impor-
tant role in protection of lungs against oxidant-induced 
injury in patients with ARDS. Bronchoalveolar lavage 
(BAL) fluid and lung tissue from patients with ARDS 
revealed increased expression of HO-1.20,31 In addi-
tion,  ischemia–reperfusion  induced  lung  injury  in 
murine models is a strong stimulator of HO-1, which 
causes protective effects and this could signify the 
HO1 expression in bronchial biopsies after long term exposure to sulfur mustard
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tissues or to remediate the oxidative damage associ-
ated with decreased blood flow.18,32
Interestingly, the expression of HO-1 is amplified 
in alveolar macrophages of lung transplant recipients 
suffered from BO and acute cellular rejection (ACR) 
and is in accordance with the capacity for rejection in 
a rat lung transplant model of ACR. In fact HO-1 has 
been demonstrated to defend lungs against this type 
of injury.20,33
In contrast to the up-regulation at mRNA level, 
immunohistochemistry staining revealed no change 
at protein level of HO-1 in bronchial epithelial cells 
in SM exposed group and we were countered with 
a discrepancy between mRNA and protein levels of 
HO-1, whereas we detected HO-1 immonopositivity 
in the unexposed group.
Our  results  from  this  study  share  similarities 
with  some  research  in  other  fields.  For  instance, 
Bruggink  showed  in  patients  with  end-stage  heart 
failure,  cathepsin  K  protein  after  Left  Ventricular 
Assist  Device  (LVAD)  decreased  in  macrophage, 
while its mRNA levels have been upregulated during 
LVAD treatment.36 Other research about the role of 
Peroxiredoxins (Prxs), a recent group of peroxidases 
with  high  antioxidant  activity  in  breast  cancer 
revealed low expression of PrxІ, ІІ, v and vІ proteins 
in contrast with high levels of mRNA.34 Although 
cited research has been focused on different tissues 
and molecules in comparison to our study, these kinds 
of paradoxical discrepancies between mRNA and pro-
tein level of HO-1 may be explained by translational 
and post translational alterations as mentioned in these 
studies.34 Conformational alterations of HO-1 protein 
following unclear mutations after SM exposure could 
be one of the reasons for this discrepancy.35 Another 
hypothesis offers destabilizing of HO-1 protein via 
phosphorylation and over oxidation which culminate 
in  protein  degradation35  which  might  refer  to  the 
secondary effect of SM.
Our  research  is  supported  with  the  imbalance 
between oxidant and antioxidant caused by reduction of 
antioxidants, which has been observed in SM exposed 
patients.9,37–39  Ghanei  and  colleagues  found  that 
N-acetyl cysteine (NAC), a mucolytic medicine with 
antioxidant effect, improved the clinical symptoms of 
Figure 2. Immunohistochemical localization of HO1 in the bronchial epithelium of human airway. A) a section from nonexposed human air way wall that 
immunostained for HO1. HO1 intensely expressed in the luminal border (Lb) and basal cells (Bc). B) No immunoreactions is seen in the human airway 
wall exposed to SM. Note to the thickness of SM exposed bronchial epithelium which significantly increased in compare to nonexposed one.
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result.
To summarize, this study demonstrated in spite of 
the fact that expression of HO-1 at mRNA levels in 
SM injured veterans significantly increased compared 
to the control group, no notable presence of HO-1 pro-
teins were reported in the airway wall of the patients. 
This finding suggests depletion of HO-1 might be a 
reasonable result for the secondary effect of SM and 
disturbing between the rate of ROS production and 
the effect of protective antioxidatiants.
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